Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.rmcr.2020.101231 http://scihub22266oqcxt.onion/10.1016/j.rmcr.2020.101231 32999856!7515585!32999856     free     free     free Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32999856.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Respir+Med+Case+Rep 2020 ; 31 (ä): 101231 Nephropedia Template TP {{tp|p=32999856|t=2020. Clinical deterioration during neutropenia recovery after G-CSF therapy in patient with COVID-19 |pdf=|usr=}}{{32999856}} gab.com Text Clinical deterioration during neutropenia recovery after G-CSF therapy in patient with COVID-19 JO: Respir Med Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=32999856 #FOAvip BACKGROUND: Granulocyte colony stimulating factors (G-CSFs) induce neutrophils proliferation and cytokines production. It has often been used to treat neutropenia without solid evidence of efficacy. It has been demonstrated that respiratory distress is associated with neutropenia recovery but not with G-CSFs. In general, G-CSFs are known to be safe and well tolerated in most clinical settings. However, the safety of G-CSFs in an overwhelming inflammatory disease like coronavirus disease 2019 (COVID-19) is largely unknown. CASE SUMMARY: We report a case with COVID-19 and neutropenia who rapidly deteriorated after administration of G-CSF. CONCLUSION: We observed a faster neutropenia recovery than previously known after administration of G-CSF in our case and in three similar cases previously reported in literature. This rapid neutropenia recovery and the robust inflammatory response in COVID-19 raise concerns about G-CSF safety in patients with COVID-19. Twit Text FOAVip Clinical deterioration during neutropenia recovery after G-CSF therapy in patient with COVID-19 ????Respir Med Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=32999856 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32999856 #FOAvip English Wikipedia <ref>{{Cite pmid|32999856}}</ref> Clinical deterioration during neutropenia recovery after G-CSF therapy in patient with COVID-19 #MMPMID32999856 Taha M; Sharma A; Soubani A Respir Med Case Rep 2020[]; 31 (ä): 101231 PMID32999856show ga BACKGROUND: Granulocyte colony stimulating factors (G-CSFs) induce neutrophils proliferation and cytokines production. It has often been used to treat neutropenia without solid evidence of efficacy. It has been demonstrated that respiratory distress is associated with neutropenia recovery but not with G-CSFs. In general, G-CSFs are known to be safe and well tolerated in most clinical settings. However, the safety of G-CSFs in an overwhelming inflammatory disease like coronavirus disease 2019 (COVID-19) is largely unknown. CASE SUMMARY: We report a case with COVID-19 and neutropenia who rapidly deteriorated after administration of G-CSF. CONCLUSION: We observed a faster neutropenia recovery than previously known after administration of G-CSF in our case and in three similar cases previously reported in literature. This rapid neutropenia recovery and the robust inflammatory response in COVID-19 raise concerns about G-CSF safety in patients with COVID-19. äClinical deterioration during neutropenia recovery after G-CSF therapy(epmc).pdf DeepDyve Pubget Overpricing